Lung Cancer Considered

Follow Lung Cancer Considered
Share on
Copy link to clipboard

Dr. Jack West hosts Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 6,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.

IASLC


    • Oct 3, 2025 LATEST EPISODE
    • weekdays NEW EPISODES
    • 37m AVG DURATION
    • 352 EPISODES


    Search for episodes from Lung Cancer Considered with a specific topic:

    Latest episodes from Lung Cancer Considered

    LCC in Arabic: WCLC 2025 Highlights

    Play Episode Listen Later Oct 3, 2025 24:40


    The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2025 in world languages. In this episode, host Dr. Nagla Abdel Karim moderates a discussion in Arabic about highlights from the conference with Dr. Riad Abdeljalil, Dr. Khaled Abdel Aziz, Dr. Ashraf Abdel Ghani, Dr. Ahmed Rabea, and Dr. Hussein Soudy.

    Lung Cancer Considered in Dutch: Targeting EGFR NSCLC

    Play Episode Listen Later Oct 3, 2025 44:06


    As part of IASLC's ongoing series of Lung Cancer Considered podcasts in world languages, Dr. Lizza Hendriks moderates a discussion in Dutch with Dr. Marthe Paats and Dr. Gerrina Ruiter on the treatment of EGFR non-small cell lung cancer.

    Lung Cancer Considered: Targeting EGFR NSCLC

    Play Episode Listen Later Oct 3, 2025 44:06


    Lung Cancer Considered: Targeting EGFR NSCLC by IASLC

    Lung Cancer Considered in Japanese---2025 WCLC Highlights

    Play Episode Listen Later Oct 2, 2025 34:51


    Lung Cancer Considered in Japanese---2025 WCLC Highlights by IASLC

    LCC in Korean: WCLC 2025 Highlights

    Play Episode Listen Later Sep 30, 2025 20:24


    The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2025 in world languages. In this episode, host Dr. Chul Kim moderates a discussion in Korean about highlights from the conference with Dr. Jeongmin Seo and Dr. Min Hee Hong. Guest Host: Chul Kim, MD, MPH Thoracic Medical Oncologist and Associate Professor Georgetown University Instagram: @fe0120 Guest Name(s) & Title(s): Jeongmin Seo, MD, MSc Assistant Professor, Medical Oncology Seoul National University Bundang Hospital Min Hee Hong, MD Associate Professor, Yonsei Cancer Center Severance Hospital, Seoul

    IASLC Lung Cancer Considered: FDA Approval: Subcutaneous Immunotherapy

    Play Episode Listen Later Sep 26, 2025 45:40


    IASLC Lung Cancer Considered: FDA Approval: Subcutaneous Immunotherapy by IASLC

    LCC in Mandarin: WCLC 2025 Highlights with Experts from Taiwan

    Play Episode Listen Later Sep 18, 2025 49:37


    The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2025 in world languages. In this episode, guest host Dr. Kuan Yu Chen moderates a discussion in Mandarin with Dr. Bin-Chi Liao and Dr. Jeng-Sen Tseng, leading lung cancer experts in Taiwan, who share their perspectives on key highlights from the conference.

    LCC in Portuguese: WCLC 2025 Highlights

    Play Episode Listen Later Sep 16, 2025 42:45


    The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2025 in world languages. In this episode, host Dr. Clarissa Mathias moderates a discussion in Portuguese about highlights from the conference with Dr. Clarissa Baldotto, Dr. Lilian Faroni, Dr. Maria Cecilia Mathias, and Dr. Wiliiam William, Jr.

    LCC in Spanish: WCLC 2025 Through a Junior Faculty Lens

    Play Episode Listen Later Sep 11, 2025 23:02


    In this episode, recorded live in Spanish at WCLC 2025, Dr. Diego Carrillo reflects on his experiences as a junior faculty member at WCLC 2025. In conversation with host Dr. Narjust Florez, they discuss conference activities, research highlights, and how WCLC helps junior faculty build their networks and shape the future of lung cancer care and research.

    spanish lens wclc junior faculty
    LCC in Hebrew: WCLC 2025 Highlights

    Play Episode Listen Later Sep 10, 2025 19:47


    The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2025 in world languages. In this episode, host Dr. Alona Zer moderates a discussion in Hebrew about highlights from the conference with Dr. Haitam Nasrallah, Dr. Jair Bar, and Dr. Ory Wiesel.

    Live From WCLC 2025: Tuesday Highlights & Meeting Summary

    Play Episode Listen Later Sep 9, 2025 43:49


    In this special WCLC 2025 episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu discuss highlights from the conference. Dr. Susan Scott discusses EGFR mutant NSCLC and results from PALOMA-2 and subcutaneous amivantamab. Dr. Wenfeng Fang discusses Iza-Bren (BL-D01D1), a first-in-class EGFR x HER-3 biospecific ADC linked to a novel topoisomerase I inhibitor payload, with promising preliminary activity in EGFR positive previously treated NSCLC. Dr. Biagio Ricciuti shares his insights from WCLC 2025, including the FLAURA-2 OS readout, the HARMONi trial in EGFR positive NSCLC, and his research in the use of immunotherapy in early-stage lung cancer.

    LCC in Spanish: WCLC 2025 Highlights

    Play Episode Listen Later Sep 9, 2025 40:07


    The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2025 in world languages. In this episode, host Dr. Narjust Florez moderates a discussion in Spanish about highlights from the conference with Dr. Laura Mezquita and Dr. Jorge Alatorre Alexander.

    Live From WCLC 2025: Monday Highlights

    Play Episode Listen Later Sep 8, 2025 42:29


    In this special WCLC 2025 episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu discuss daily highlights from the conference. Dr. Tina Cascone discusses results from the NADIM ADJUVANT Phase III trial. Dr. Jacie Jiaqi Law shares survival outcomes of VATS compared to open lobectomy, and Dr. Corinne Faivre-Finn and Dr. Shankar Siva summarize results from the EA5181 trial of concurrent and consolidation durvalumab after chemoradiation for unresectable NSCLC and hypofractionation vs conventional fractionation for LS SCLC.

    LCC in Mandarin: WCLC 2025 Highlights

    Play Episode Listen Later Sep 8, 2025 35:32


    The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2025 in world languages. In this episode, host Dr. Chunxia Su moderates a discussion in Mandarin Chinese about highlights from the conference with Dr. Yang Xia and Dr. Nan Bi.

    Live From WCLC 2025: Sunday Highlights

    Play Episode Listen Later Sep 7, 2025 24:29


    In this special WCLC 2025 episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu discuss daily highlights from the conference. Dr. David Planchard discusses the data that we all were waiting for the FLAURA-2 overall survival. Dr. Alexander Drilon shares results from the ARROS-1 study including efficacy results and safety data for zidesamtinib, a new ROS1 inhibitor that could change the landscape in the ROS1 space.

    ros1 flaura wclc
    "I'm in Barcelona, Now What?" — Tips for First-Time WCLC Attendees

    Play Episode Listen Later Sep 6, 2025 19:07


    In this episode of Lung Cancer Considered, Dr. Narjust Florez and Dr. Stephen Liu share tips for first-time attendees of the World Conference on Lung Cancer (WCLC). Recorded live at WCLC 2025, hear their 10 key recommendations to make the most of your experience, including advice on how to sneak self-care into your busy conference schedule.

    LCC in Mandarin: Neoadjuvant and Perioperative Therapy for Locally Advanced NSCLC

    Play Episode Listen Later Aug 29, 2025 52:17


    LCC in Mandarin: Neoadjuvant and Perioperative Therapy for Locally Advanced NSCLC by IASLC

    IASLC - ALK Positive Summit

    Play Episode Listen Later Aug 26, 2025 38:16


    IASLC - ALK Positive Summit by IASLC

    LCC in Greek: Virtual Tumor Board - ALK NSCLC

    Play Episode Listen Later Aug 22, 2025 60:42


    LCC in Greek: Virtual Tumor Board - ALK NSCLC by IASLC

    Lung Cancer Considered--STK11 and KEAP1 as resistance mechanisms to immunotherapy

    Play Episode Listen Later Aug 19, 2025 53:26


    Lung Cancer Considered--STK11 and KEAP1 as resistance mechanisms to immunotherapy by IASLC

    LCC in Cantonese: Novel Treatment for Advanced EGFR Mutant Lung Cancer

    Play Episode Listen Later Aug 15, 2025 64:39


    LCC in Cantonese: Novel Treatment for Advanced EGFR Mutant Lung Cancer by IASLC

    FDA Approval: Zongertinib for HER2 Mutant NSCLC

    Play Episode Listen Later Aug 12, 2025 41:55


    FDA Approval: Zongertinib for HER2 Mutant NSCLC by IASLC

    LCC in Arabic: Arab Women's Voices in Thoracic Oncology

    Play Episode Listen Later Aug 8, 2025 33:30


    As part of IASLC's ongoing series of podcasts in world languages, Dr. Nagla Abdel Karim moderates a discussion in Arabic with Dr. Asrar AlAhmadi and Dr. Maya Khalil. The group discusses the journey and career development of Arabic women in the field of thoracic oncology.

    Artificial Intelligence (AI) and Lung Cancer Treatment Decisions

    Play Episode Listen Later Aug 5, 2025 45:33


    Artificial Intelligence (AI) and Lung Cancer Treatment Decisions by IASLC

    Artificial Intelligence (AI) and Lung Cancer Treatment Decisions

    Play Episode Listen Later Aug 5, 2025 45:33


    Artificial Intelligence (AI) and Lung Cancer Treatment Decisions by IASLC

    LCC in Romanian: Management of Unresectable, EGFR-mutated Stage III Lung Cancer in Romania

    Play Episode Listen Later Aug 2, 2025 47:08


    LCC in Romanian: Management of Unresectable, EGFR-mutated Stage III Lung Cancer in Romania by IASLC

    IASLC - Stigma

    Play Episode Listen Later Jul 29, 2025 57:13


    IASLC - Stigma by IASLC

    LCC in Japanese: ASCO 2025 Highlights

    Play Episode Listen Later Jul 25, 2025 34:11


    LCC in Japanese: ASCO 2025 Highlights by IASLC

    Preview: IASLC | ASCO 2025 North American Conference on Lung Cancer

    Play Episode Listen Later Jul 23, 2025 22:40


    On December 5, 2025, we will kick off the IASLC ASCO 2025 North America Conference on Lung Cancer. Guest include Dr. Ramesh Rengan, the Peter Wootton Professor and Chair of Radiation Oncology at the University of Washington and Senior Vice President of the Fred Hutchinson Cancer Center and Dr. Kristen Marrone, Associate Professor of Oncology and Director of the Medical Oncology and Hematology Fellowship Program at Johns Hopkins University.

    FDA Approval: Datopotamab Deruxtecan for EGFR NSCLC

    Play Episode Listen Later Jul 18, 2025 45:33


    FDA Approval: Datopotamab Deruxtecan for EGFR NSCLC by IASLC

    FDA Approval: Sunvozertinib for EGFR Exon 20

    Play Episode Listen Later Jul 15, 2025 41:03


    FDA Approval: Sunvozertinib for EGFR Exon 20 by IASLC

    LCC in Portuguese: Virtual Tumor Board - EGFR NSCLC

    Play Episode Listen Later Jul 11, 2025 46:33


    LCC in Portuguese: Virtual Tumor Board - EGFR NSCLC by IASLC

    IASLC_WCLC 2025 Preview

    Play Episode Listen Later Jul 8, 2025 45:13


    IASLC_WCLC 2025 Preview by IASLC

    Virtual Tumor Board: Resectable EGFR NSCLC

    Play Episode Listen Later Jul 1, 2025 39:29


    In this episode of Lung Cancer Considered, host Dr. Stephen Liu moderates a Virtual Tumor Board case with Dr. Chunxia Su and Dr. Collin Blakely. The case explores resectable EGFR NSCLC.

    FDA Approval: Taletrectinib and ROS1 NSCLC

    Play Episode Listen Later Jun 24, 2025 29:20


    In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses the recent FDA approval of taletrectinib, a next-generation ROS1 kinase inhibitor, for NSCLC with a ROS1 gene fusion. Dr. Enriqueta Felip and Dr. Jorge Nieva join the conversation to help review the data and offer help place this new agent in the proper perspective.

    IASLC - ASCO 2025 Highlights

    Play Episode Listen Later Jun 6, 2025 55:15


    ASCO 2025 Highlights Guests: Charu Aggarwal, MD, MPH Leslye M. Heisler Professor of Medicine Section Chief, Thoracic and Head & Neck Cancer Associate Director, Penn Center for Cancer Care Innovation (PC3I) University of Pennsylvania Patrick Forde, MBBCh Associate Professor Johns Hopkins University

    FDA Approval: Telisotuzumab Vedotin and MET-Positive NSCLC

    Play Episode Listen Later May 27, 2025 33:15


    In this episode, we will discuss the FDA approval of telisotuzumab vedotin, an antibody drug conjugate, for NSCLC with high c-MET expression. To help review the data and offer perspective on this new agent, I am joined by two expert thoracic oncologists. I want to welcome Dr. Mor Moskovitz, Head of the Thoracic Medical Oncology Service at Davidoff Cancer Center at the Rabin Medical Center in Petah Tikva, Israel.

    LCC in Korean: Lung Cancer Updates & Future Directions

    Play Episode Listen Later May 23, 2025 33:41


    LCC in Korean: Lung Cancer Updates & Future Directions by IASLC

    Global Advances and Persistent Disparities in Lung Cancer Treatment

    Play Episode Listen Later May 20, 2025 47:50


    Global Advances and Persistent Disparities in Lung Cancer Treatment by IASLC

    Dr. Bryant Lin Teaching My Cancer

    Play Episode Listen Later May 6, 2025 41:26


    Dr. Bryant Lin Teaching My Cancer by IASLC

    AACR 2025 Highlights

    Play Episode Listen Later May 2, 2025 52:03


    AACR 2025 Highlights by IASLC

    What You Should Know About RET-Positive NSCLC: Live from TexasLung25

    Play Episode Listen Later Apr 29, 2025 30:48


    In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion live from the Texas Lung Cancer Conference with Dr. Mihaela Aldea about the key information about RET-positive NSCLC, from diagnostic challenges to treatment selection. Join us in this lively discussion.

    Live from Texas Lung - Patient Education

    Play Episode Listen Later Apr 22, 2025 40:46


    Live from Texas Lung - Patient Education by IASLC

    ELCC 2025 Highlights

    Play Episode Listen Later Apr 6, 2025 43:04


    Guest: Dr. Corey Langer is the Director of Thoracic Oncology and Professor of Medicine at the Hospital of the University of Pennsylvania

    Lung Cancer Considered-Stigma

    Play Episode Listen Later Mar 16, 2025 57:13


    Lung Cancer Considered-Stigma by IASLC

    Virtual Tumor Board: Targeting Residual Disease

    Play Episode Listen Later Mar 16, 2025 49:11


    Virtual Tumor Board: Targeting Residual Disease by IASLC

    LCC in Korean: 2024 Lung Cancer Updates

    Play Episode Listen Later Mar 16, 2025 33:41


    LCC in Korean: 2024 Lung Cancer Updates by IASLC

    The Microbiome and Immunotherapy for Lung Cancer

    Play Episode Listen Later Mar 16, 2025 50:55


    The Microbiome and Immunotherapy for Lung Cancer by IASLC

    Live from TTLC25: Brain Metastasis

    Play Episode Listen Later Mar 16, 2025 19:11


    Live from TTLC25: Brain Metastasis by IASLC

    LCC in Mandarin: Virtual Tumor Board - EGFR NSCLC

    Play Episode Listen Later Mar 16, 2025 28:05


    LCC in Mandarin: Virtual Tumor Board - EGFR NSCLC by IASLC

    Lung Cancer Considered in Turkish

    Play Episode Listen Later Mar 16, 2025 56:03


    Host: Ece Cali Daylan, Assistant Professor of Medicine, Division of Oncology at Washington University School of Medicine Guest: Saadettin Kilickap Guest: Ozden Altundag

    Claim Lung Cancer Considered

    In order to claim this podcast we'll send an email to with a verification link. Simply click the link and you will be able to edit tags, request a refresh, and other features to take control of your podcast page!

    Claim Cancel